Emotional Triggering of Cardiac Dysfunction: The Present and Future

Current Cardiology Reports

Volumn 17, Issue 10, 2015, Pages

  Jiang, Wei ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Mental stress induced cardiac dysfunction; Mitochondrial dysfunction

Indexed keywords

ESCITALOPRAM; PLACEBO;

BLOOD PRESSURE; CORONARY ARTERY CONSTRICTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HUMAN; KINESIOTHERAPY; MENTAL STRESS; MENTAL STRESS INDUCED MYOCARDIAL ISCHEMIA; MENTAL STRESS MYOCARDIAL ISCHEMIA; PATHOGENESIS; PHYSICAL STRESS; PREVALENCE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; STRESS MANAGEMENT; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTE AGGREGATION; ADAPTIVE BEHAVIOR; AUTONOMIC NERVOUS SYSTEM; COMPLICATION; CORONARY ARTERY DISEASE; EMOTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK FACTOR;

ADAPTATION, PSYCHOLOGICAL; AUTONOMIC NERVOUS SYSTEM; CORONARY ARTERY DISEASE; EMOTIONS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84940179843     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-015-0635-3     Document Type: Review

References (60)

1. WHO Cardiovascular Diseases Fact Sheet. 2015. (Accessed May 11, 2015).
2. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–322.
3. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192–217.
4. Cohen S, Janicki-Deverts D, Miller G. Psychological stress and disease. JAMA. 2007;298:1685–7.
5. Kaplan J, Chen H, Manuck SB. The relationship between social status and atherosclerosis in male and female monkeys as revealed by meta-analysis. Am J Primatol. 2009;71:732–41.
6. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.
7. Jiang W, Babyak MA, Rozanski A, Sherwood A, O'Connor CM, Waugh RA, et al. Depression and increased myocardial ischemic activity in patients with ischemic heart disease. Am Heart J. 2003;146:55–61.
8. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol. 2005;45:637–51.
9. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334:413–9.
10. Nozaki E, Nakamura A, Abe A, Kagaya Y, Kohzu K, Sato K, et al. Occurrence of cardiovascular events after the 2011 Great East Japan Earthquake and tsunami disaster. Int Heart J. 2013;54:247–53. This study again reported the association of environmental accident and increased cardiovascular events.
11. Deanfield J, Shea M, Kensett M, Horlock P, Wilson RA, de Landsheere CM, et al. Silent myocardial ischaemia due to mental stress. Lancet. 1984;2:1001–5.
12. Rozanski A, Bairey CN, Krantz DS, Friedman J, Resser KJ, Morell M, et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med. 1988;318:1005–12.
13. Jiang W, Babyak M, Krantz DS, Waugh RA, Coleman RE, Hanson MM, et al. Mental stress-induced myocardial ischemia and cardiac events. JAMA. 1996;275:1651–6.
14. Strike P, Steptoe A. Systematic review of mental stress-induced myocardial ischaemia. Eur Heart J. 2003;24:690–703.
15. Barbirato G, Félix R, de Azevedo JC, Corrêa PL, de Nóbrega AC, Coimbra A, et al. Prevalence of induced ischemia by mental distress. Arq Bras Cardiol. 2010;94:321–7.
16. Ramachandruni S, Fillingim RB, McGorray SP, Schmalfuss CM, Cooper GR, Schofield RS, et al. Mental stress provokes ischemia in coronary artery disease subjects without exercise- or adenosine-induced ischemia. J Am Coll Cardiol. 2006;47:987–91.
17. Hassan M, York KM, Li Q, Lucey DG, Fillingim RB, Sheps DS. Variability of myocardial ischemia responses to mental stress versus exercise or adenosine stress in patients with coronary artery disease. J Nucl Cardiol. 2008;15:518–25.
18. Jiang W, Samad Z, Boyle S, Becker RC, Williams R, Kuhn C, et al. Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease. J Am Coll Cardiol. 2013;61:714–22. This is the first study describing MSIMI is more frequent in clinically stable IHD population and identified women are more prone to MSIMI and married men are best protected from having MSIMI.
19. York K, Hassan M, Li Q, Li H, Fillingim RB, Lucey D, et al. Do men and women differ on measures of mental stress-induced ischemia. Psychosom Med. 2007;69:918–22.
20. Samad Z, Boyle S, Ersboll M, Vora AN, Zhang Y, Becker RC, et al. Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study. J Am Coll Cardiol. 2014;64:1669–78. This is the first study that discussed comprehensively that characteristics of women’s psychological and physiological responses to emotional stress.
21. Vaccarino V, Shah AJ, Rooks C. Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med. 2014;76:171–80. This study confirms women are more prone to have MSIMI than men, and first noted such phenomena occurs in younger individuals (age <50 year-old).
22. Peix A, Trápaga A, Asen L, Ponce F, Infante O, Valiente J, et al. Mental stress-induced myocardial ischemia in women with angina and normal coronary angiograms. J Nucl Cardiol. 2006;13:507–13.
23. Johnson B, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J. 2006;27:1408–15.
24. Pepine C. Ischemic heart disease in women. J Am Coll Cardiol. 2006;47:S1–3.
25. Min J, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, et al; CONFIRM Investigators. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58:849–60.
26. Boyle S, Samad Z, Becker RC, Williams R, Kuhn C, Ortel TL, et al. Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease. Psychosom Med. 2013;75:822–31. Aiming at replicate previous found associations of depression and MSIMI.
27. Wei J, Rooks C, Ramadan R, Shah AJ, Bremner JD, Quyyumi AA, et al. Meta-analysis of mental stress-induced myocardial ischemia and subsequent cardiac events in patients with coronary artery disease. Am J Cardiol. 2014;114:187–92. A meta-analysis confirms the association of MSIMI and increased poor CV prognosis.
28. Burg M, Meadows J, Shimbo D, Davidson KW, Schwartz JE, Soufer R. Confluence of depression and acute psychological stress among patients with stable coronary heart disease: effects on myocardial perfusion. J Am Heart Assoc. 2014;3:e000898. Duplicative findings confirming the association of depression and MSIMI.
29. Pimple P, Shah A, Rooks C, Bremner JD, Nye J, Ibeanu I, et al. Association between anger and mental stress-induced myocardial ischemia. Am Heart J. 2015;169:115–21. This study indicates certain measures of anger may be related to MSIMI.
30. Babyak M, Blumenthal JA, Hinderliter A, Hoffman B, Waugh RA, Coleman RE, et al. Prognosis after change in left ventricular ejection fraction during mental stress testing in patients with stable coronary artery disease. Am J Cadiol. 2010;105:25–8.
31. Wei J, Pimple P, Shah AJ, Rooks C, Bremner JD, Nye JA, et al. Depressive symptoms are associated with mental stress-induced myocardial ischemia after acute myocardial infarction. PLoS One. 2014;9(7):e102986. doi:10.1371/journal.pone.0102986. eCollection 2014. Duplicative findings confirming the association of depression and MSIMI.
32. Jiang W, Velazquez EJ, Samad Z, Kuchibhatla M, Martsberger C, Rogers J, et al. Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress-Induced Myocardial Ischemia to Escitalopram Treatment trial. Am Heart J. 2012;163:20–6.
33. Ersbøll M, Al Enezi F, Samad Z, Sedberry B, Boyle SH, O'Connor C, et al. Impaired resting myocardial annular velocities are independently associated with mental stress-induced ischemia in coronary heart disease. JACC Cardiovasc Imaging. 2014;7:351–61. First study using parameters that are more sensitive to conventional ischemic measures demonstrating occurrence of MSIMI.
34. Akinboboye O, Krantz DS, Kop WJ, Schwartz SD, Levine J, Del Negro A, et al. Comparison of mental stress-induced myocardial ischemia in coronary artery disease patients with versus without left ventricular dysfunction. Am J Cardiol. 2005;95:322–6.
35. Hassan M, York KM, Li H, Li Q, Sheps DS. Mental stress-induced myocardial ischemia in coronary artery disease patients with left ventricular dysfunction. J Nucl Cardiol. 2007;14:308–13.
36. Paulus W, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263–71. Mechanistic study examining the microvascular endothelial inflammation and ejection fraction reserved heart failure.
37. Jiang W, Qi L, Martsberger CM, Samad Z, Rogers J, Krishnan R, Williams R, O’Connor CM, Velazquez EJ. Relationship of Resting Diastolic Function and Stress Induced Left Ventricular Dysfunction in Patients with Stable Coronary Heart Disease. 69th APS Annual Meeting 2011;A–74:310.
38. Ramadan R, Sheps D, Esteves F, Maziar Zafari A, Bremner JD, Vaccarino V, et al. Myocardial ischemia during mental stress: role of coronary artery disease burden and vasomotion. J Am Heart Assoc. 2013;2:e000321. A study using a very conveniently applied tool to assess the peripheral vascular resistance in relationship of MSIMI and physical stress-induced myocardial ischemia.
39. Jiang W, Boyle SH, Ortel TL, Samad Z, Velazquez EJ, Harrison RW, et al. Platelet aggregation and mental stress induced myocardial ischemia: results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study. Am Heart J. 2015;169:496–507. This study not only demonstrates the significant change of platelet aggregation under mental stress in patients with MSIMI, but it also indicates that using mental stress testing is a necessary method to investigate certain dynamic changes in the cardiovascular system.
40. Shah S, Kraus WE, Newgard CB. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation. 2012;126:1110–20.
41. Boyle S, Matson WR, Velazquez EJ, Samad Z, Williams Jr RB, Sharma S, et al. Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunction. Metabolomics. 2015;11:571–82. While this study has small sample size, it is novel as it demonstrates the applicability of metabolomics technology is practicable in identifying alterations of metabolites separating mental stress caused from resting and having mental stress-induced left ventricular dysfunction from normal responses of left ventricle.
42. Jiang W, Velazquez EJ, Kuchibhatla M, Samad Z, Boyle SH, Kuhn C, et al. Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial. JAMA. 2013;309:2139–49. This is the first study examining and demonstrating that SSRI improves MSIMI.
43. Blumenthal J, Sherwood A, Babyak MA. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA. 2005;293:1626–34.
44. Marzilli M, Merz CN, Boden WE, Bonow RO, Capozza PG, Chilian WM, et al. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link. J Am Coll Cardiol. 2012;60:951–6.
45. Bendheim P, Poeggeler B, Neria E, Ziv V, Pappolla MA, Chain DG. Development of indole-3-propionic acid (OXIGON) for Alzheimer’s disease. J Mol Neurosci. 2002;19:213–7.
46. Steffens D, Jiang W, Krishnan KR, Karoly ED, Mitchell MW, O'Connor CM, et al. Metabolomic differences in heart failure patients with and without major depression. J Geriatr Psychiatry Neurol. 2010;23:138–46.
47. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161:1849–56.
48. Adams J, Kuchibhatla M, Christopher EJ, Alexander JD, Clary GL, Cuffe MS, et al. Association of depression and survival in patients with chronic heart failure over 12 Years. Psychosomatics. 2012;53:339–46.
49. Rasbach K, Funk JA, Jayavelu T, Green PT, Schnellmann RG. 5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis. J Pharmacol Exp Ther. 2010;332:632–9.
50. Nebigil C, Jaffré F, Messaddeq N, Hickel P, Monassier L, Launay JM, et al. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation. 2003;107:3223–9.
51. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, et al. Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci U S A. 2009;106:3543–8.
52. Davidson S. Duchen MR Endothelial mitochondria: contributing to vascular function and disease. Circ Res. 2007;100:1128–41.
53. Krantz D, Burg MM. Current perspective on mental stress-induced myocardial ischemia. Psychosom Med. 2014;76:168–70. A good expert opinion paper discussing MSIMI.
54. Dromparis P, Michelakis ED. Mitochondria in vascular health and disease. Annu Rev Physiol. 2013;75:95–126. A good review paper discussing the role of mitochondria in the health and diseases related to vascular functions.
55. Kluge M, Fetterman JL, Vita JA. Mitochondria and endothelial function. Circ Res. 2013;112:1171–88. A good review article discussing the role of mitochondria in endothelial function and dysfunction in relationship to many diseases.
56. Tang X, Luo YX, Chen HZ, Liu DP. Mitochondria, endothelial cell function, and vascular diseases. Front Physiol. 2014;5:175. A thorough review article discussing the role of mitochondria in endothelial function and dysfunction in relationship to many diseases.
57. Rosca M, Hoppel CL. Mitochondria in heart failure. Cardiovas Res. 2010;88:40.
58. Griffiths E. Mitochondria and heart disease. Adv Exp Med Biol. 2012;942
59. Walters A, Porter GA, Brookes PS. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ Res. 2012;111:1222–36.
60. Dorn G. Mitochondrial dynamics in heart disease. Biochimica et Biophysica Acta Mol Cell Res. 2013;1833:233–41. A thorough review article discussing the role of mitochondrial dynamics in heart disease.